2 of the best FTSE 100 stocks to buy today

The FTSE 100 index is in the red today, but not all stocks are doing badly. These two, for instance, are among the biggest gainers. 

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It may be an awful day for the markets, but not all stocks are losers. There are at least a handful of FTSE 100 stocks that are making fairly decent gains. No prizes for guessing which these are though. These are the classic defensive shares investors buy when there is some serious economic and stock market uncertainty around. 

These include the healthcare biggie and Covid-19 vaccine developer AstraZeneca (LSE: AZN) and precious metals miner Polymetal International (LSE: POLY). While the AstraZeneca stock is up some 3% as I write, Polymetal International is up 1.4%. If stock markets keep falling, I think I can be fairly certain that both stocks will have further upside to them. 

AstraZeneca is a dependable healthcare stock

Being a healthcare company, AstraZeneca’s treatments are in demand even during times of economic slowdowns. Additionally, the fact that they are successful and widely accepted makes it an even more coveted stock to hold. This shows up in its financials too. This makes AZN a far safer place for me to park my funds than real estate and industrial metals stocks that are vulnerable to withdrawal of fiscal stimulus by governments. 

That said, it is not devoid of its own, very particular, challenges. For instance, the company was in disagreement with the European Union earlier this year regarding the distribution of vaccines. Also there were questions around the efficacy of the vaccine itself. Despite all this, it has always been a pricey stock. Its current price-to-earnings (P/E) ratio is at 39 times, and this is among the lowest I have seen since I started tracking the stock. 

Polymetal International is a precious metals play

Polymetal International mines gold and silver, both of which see rising demand during uncertain times. Last year was a good example of this. As stock markets crashed, gold prices rallied. They only slowed their upward climb when the economic outlook improved. 

But I like the stock because of its performance even before the gold price rally started. Since 2017, the company has seen a consistent rise in both its revenues and profits. In other words, even if it benefits from higher gold prices, its performance is not dependent on them, which makes it a far more dependable stock to hold than many others. It also has a dividend yield of a high 7.4%. 

The only catch to the stock, I feel, is the share price crash it has seen. In the last year, it has fallen by more than 25%. This is a big downer, but then again it is potentially good for portfolio de-risking when there is a slowdown. Also, I think that as its share price has fallen so much, that it was only a matter of time before it started rising. 

Would I buy these FTSE 100 shares?

I bought both stocks a while ago. And this is only partly because of their defensive nature. I just really liked their performance. And over time, if it is maintained, it only goes in the stocks’ favour. They are still good buys, in my view.

Manika Premsingh owns shares of AstraZeneca and Polymetal International. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing For Beginners

1 FTSE 250 stock I like and 1 I’ll avoid after the stock market correction

Jon Smith analyses the move lower in certain FTSE 250 companies over the past month and picks one that looks…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

Is April 2026 a great time to buy Lloyds shares?

Lloyds shares have been flying over the last two years. And there's one factor that could mean the bank continues…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Want to aim for a £500 second income each month? Here’s how much it takes

Christopher Ruane digs into the numbers and mechanics that could let someone with no shares today build an annual second…

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

Down 95%, what might it take for the Aston Martin share price to rise 2,000%?

The Aston Martin share price has collapsed. Our writer considers what it might take for it to regain some ground…

Read more »

Investing Articles

How are Diageo shares looking in April 2026?

It's been an eventful year so far, but what has the impact been for Diageo shares, and where might they…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

P/Es below 7! 3 staggeringly cheap shares despite yesterday’s rally

Investors who fear they have missed their opportunity to buy cheap shares as the stock market recovers might want to…

Read more »

ISA coins
Investing Articles

Want to know what UK investors have been buying in their ISAs?

Looking for stock, trust, and fund ideas this April? Royston Wild discusses what Brits have been stuffing in their Stocks…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Why aren’t people buying Greggs shares by the bucketload?

Greggs' shares remain in the doldrums. But should Foolish investors consider pouncing while others won't? Paul Summers takes a fresh…

Read more »